Medicine and Dentistry
Thromboxane A2
100%
Thromboxane Receptor
100%
Atherogenesis
100%
Receptor Blocking
100%
Chemotherapeutic Agent
66%
Drug
66%
Biosynthesis
66%
5 (4 Chlorophenyl) 1 (4 Methoxyphenyl) 3 Trifluoromethyl 1h Pyrazole
66%
Macrophage
33%
Therapeutic Procedure
33%
Plasma
33%
Phenotype
33%
Ligand
33%
Smooth Muscle Cell
33%
Collagen
33%
Triacylglycerol
33%
Body Weight
33%
Lipid Diet
33%
Lesion
33%
Cholesterol
33%
Prostacyclin
33%
Vasculitis
33%
Thromboxane
33%
LDL Receptor
33%
Isoprostane Derivative
33%
Cyclooxygenase 1 Inhibitor
33%
Pharmacology, Toxicology and Pharmaceutical Science
Thromboxane Receptor
100%
Thromboxane A2
100%
Atherogenesis
100%
Low Density Lipoprotein Receptor Knockout Mouse
100%
Drug
66%
Mouse
66%
5 (4 Chlorophenyl) 1 (4 Methoxyphenyl) 3 Trifluoromethyl 1h Pyrazole
66%
Ligand
33%
Collagen
33%
Fat
33%
Triacylglycerol
33%
Thromboxane
33%
Cholesterol
33%
Prostacyclin
33%
Low Density Lipoprotein Receptor
33%
Cyclooxygenase 1 Inhibitor
33%
Vasculitis
33%
Isoprostane Derivative
33%
Food Science
Cholesterol
100%
Diet
100%